TABLE OF CONTENTS
Volume 77, Issue 5 (May 2005)
Pharmacogenetics and Genomics |
Pharmacokinetics and Drug Disposition |
Clinical Trials |
Pharmacodynamics and Drug Action |
Letters to the Editor |
Book Received |
Corrections
Perspectives in Clinical Pharmacology
Cytochrome P450 2C8: Substrates, Inhibitors, Pharmacogenetics, and Clinical Relevance
Rheem A. Totah PhD and Allan E. Rettie PhD
Clin Pharmacol Ther 77: 341-352; doi:10.1016/j.clpt.2004.12.267
Pharmacogenetics and Genomics
CYP2C9 Haplotype Structure in European American Warfarin Patients and Association with Clinical Outcomes
David L. Veenstra, David K. Blough, Mitchell K. Higashi, Frederico M. Farin, Sengkeo Srinouanprachan, Mark J. Rieder and Allan E. Rettie
Clin Pharmacol Ther 77: 353-364; doi:10.1016/j.clpt.2005.01.019
Common Genetic Variants of Microsomal Epoxide Hydrolase Affect Warfarin Dose Requirements Beyond the Effect of Cytochrome P450 2C9
Ronen Loebstein MD, Manuela Vecsler BSc, Daniel Kurnik MD, Naomi Austerweil BSc, Eva Gak PhD, Hillel Halkin MD and Shlomo Almog PhD
Clin Pharmacol Ther 77: 365-372; doi:10.1016/j.clpt.2005.01.010
Genotype-phenotype Associations of Cytochrome P450 3A4 and 3A5 Polymorphism with Midazolam Clearance in Vivo
Ping He MD, Michael H. Court BVSc, PhD, David J. Greenblatt MD and Lisa L. von Moltke MD
Clin Pharmacol Ther 77: 373-387; doi:10.1016/j.clpt.2004.11.112
Human Response to 
2-adrenergic Agonist Stimulation Studied in an Isolated Vascular Bed in Vivo: Biphasic Influence of Dose, Age, Gender, and Receptor Genotype
Danuta King MD, Jason P. Etzel BS, Shagun Chopra MD, Joshua Smith BS, Peter E. Cadman MD, Fangwen Rao MD, Stephen D. Funk PharmD, Brinda K. Rana PhD, Nicholas J. Schork PhD, Paul A. Insel MD and Daniel T. O'Connor MD
Clin Pharmacol Ther 77: 388-403; doi:10.1016/j.clpt.2005.02.008
Pharmacokinetics and Drug Disposition
Effects of Gemfibrozil, Itraconazole, and Their Combination on the Pharmacokinetics of Pioglitazone
Tiina Jaakkola MD, Janne T. Backman MD, Mikko Neuvonen MSc and Pertti J. Neuvonen MD
Clin Pharmacol Ther 77: 404-414; doi:10.1016/j.clpt.2004.12.266
In Vivo Effects of Goldenseal, Kava Kava, Black Cohosh, and Valerian on Human Cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 Phenotypes
Bill J. Gurley PhD, Stephanie F. Gardner PharmD, EdD, Martha A. Hubbard MS, D. Keith Williams PhD, W. Brooks Gentry MD, Ikhlas A. Khan PhD and Amit Shah
Clin Pharmacol Ther 77: 415-426; doi:10.1016/j.clpt.2005.01.009
Clinical Trials
A Pharmacokinetic-pharmacodynamic Model for the Mobilization of CD34+ Hematopoietic Progenitor Cells by AMD3100
N. A. Lack BSc, B. Green MSc, DPh, D. C. Dale MD, G. B. Calandra MD, PhD, H. Lee MD, PhD, R. T. MacFarland PhD, K. Badel BScN, W. C. Liles MD, PhD and G. Bridger PhD
Clin Pharmacol Ther 77: 427-436; doi:10.1016/j.clpt.2004.12.268
Pharmacodynamics and Drug Action
Renal Effects of the Cyclooxygenase-inhibiting Nitric Oxide Donator AZD3582 Compared with Rofecoxib and Naproxen During Normal and Low Sodium Intake
Gunilla Huledal MSc(Pharm), Bror Jonzon MD, PhD, Maria Malmenäs MSc, Ann Hedman MSc(Pharm), PhD, Lars I. Andersson PhD, Bo Odlind MD, PhD and D. Craig Brater MD
Clin Pharmacol Ther 77: 437-450; doi:10.1016/j.clpt.2005.01.011
Letters to the Editor
Herbal Medicines in Malaysia
Hooi-Hoon Ang BPharm(Hons), PhD
Clin Pharmacol Ther 77: 451; doi:10.1016/j.clpt.2005.01.016
Linezolid and Rifampin: Drug Interaction Contrary to Expectations?
Hannes Egle PhD, Rainer Trittler PhD, Klaus Kümmerer and Sebastian W. Lemmen MD
Clin Pharmacol Ther 77: 451-453; doi:10.1016/j.clpt.2005.01.020
Traditional Aqueous Kava Extracts Inhibit Cytochrome P450 1A2 in Humans: Protective Effect Against Environmental Carcinogens?
Stefan Russmann MD, Bernhard H. Lauterburg MD, Yann Barguil PharmD, Erwan Choblet MD, Pierre Cabalion PhD, Katharina Rentsch PhD and Markus Wenk PhD
Clin Pharmacol Ther 77: 453-454; doi:10.1016/j.clpt.2005.01.021
Book Received
Books Received
Clin Pharmacol Ther 77: 455-456; doi:10.1016/j.clpt.2005.02.007
